Keros Therapeutics, Inc. Annual Return On Assets in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Keros Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2020 to 2023.
  • Keros Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -38.4 %, a 7.38% increase year-over-year.
  • Keros Therapeutics, Inc. annual Return On Assets for 2023 was -42.6 %, a 3.85% decline from 2022.
  • Keros Therapeutics, Inc. annual Return On Assets for 2022 was -41 %, a 72.1% decline from 2021.
  • Keros Therapeutics, Inc. annual Return On Assets for 2021 was -23.8 %, a 18.8% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -42.6 -1.58 -3.85% Jan 1, 2023 Dec 31, 2023
2022 -41 -17.2 -72.1% Jan 1, 2022 Dec 31, 2022
2021 -23.8 +5.5 +18.8% Jan 1, 2021 Dec 31, 2021
2020 -29.3 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.